Connor, Clark & Lunn Investment Management (CC&L)’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,770
| Closed | -$151K | – | 1543 |
|
|
2024
Q2 | $151K | Buy |
+18,770
| New | +$151K | ﹤0.01% | 1286 |
|
|
2022
Q4 | – | Sell |
-15,250
| Closed | -$146K | – | 1318 |
|
|
2022
Q3 | $146K | Buy |
+15,250
| New | +$146K | ﹤0.01% | 1024 |
|
|
2022
Q1 | – | Sell |
-10,428
| Closed | -$199K | – | 1122 |
|
|
2021
Q4 | $199K | Sell |
10,428
-20,124
| -66% | -$384K | ﹤0.01% | 982 |
|
|
2021
Q3 | $753K | Buy |
+30,552
| New | +$753K | ﹤0.01% | 693 |
|
|
2016
Q1 | – | Sell |
-31,200
| Closed | -$241K | – | 869 |
|
|
2015
Q4 | $241K | Sell |
31,200
-3,500
| -10% | -$27K | ﹤0.01% | 670 |
|
|
2015
Q3 | $200K | Buy |
+34,700
| New | +$200K | ﹤0.01% | 644 |
|